Register for VENCLEXTA™ updates
By registering at this site you certify that you are a healthcare
professional licensed in the United States or its territories and are
indicating that you wish to receive information about VENCLEXTA and
related disease education. AbbVie and Genentech intend to only provide
information to healthcare professionals licensed in the United States
or its territories who would likely be treating patients within the
FDA-approved indications for this product.
Thank you. You have successfully registered to receive updates from VENCLEXTA™.